News

David Smits, MD, Named Richard J. Simmons and Ruthanne B. Simmons Glaucoma Fellow

April 23, 2019
Dr. David SmitsDavid Smits, MD, has been named the 2018-2019 Richard J. Simmons and Ruthanne B. Simmons Glaucoma Fellow in the Harvard Department of Ophthalmology. This annual award was established in 2011 in recognition of two glaucoma physicians who were Harvard Ophthalmology graduates: the late Dr. Ruthanne Simmons and her father Dr. Richard Simmons... Read more about David Smits, MD, Named Richard J. Simmons and Ruthanne B. Simmons Glaucoma Fellow

Study Led by Michael Gilmore, PhD, Identifies Pathway for how Enterococcus Faecalis Bacteria Causes Antibiotic-Resistant Infection

April 18, 2019

A new study led by a research team from Harvard Medical School and Mass. Eye and Ear, describes how bacteria adapted to the modern hospital environment and repeatedly cause antibiotic-resistant bloodstream infections. This study examined one of the first sustained hospital outbreaks of a multidrug-resistant bacterium, Enterococcus faecalis, which occurred from the early through the mid-1980s, causing over 60 outbreak strains.... Read more about Study Led by Michael Gilmore, PhD, Identifies Pathway for how Enterococcus Faecalis Bacteria Causes Antibiotic-Resistant Infection

Lucia Sobrin, MD, MPH, Recognized with Harvard Ophthalmology Excellence in Mentoring Award

April 9, 2019

Lucia Sobrin Receives Mentoring Award

Congratulations to Lucia Sobrin, MD, MPH, director of the Morse Laser Center at Mass. Eye and Ear, on receiving the inaugural Harvard Ophthalmology Excellence in Mentoring Award. The Harvard Ophthalmology Mentoring program was created in 2014 to help direct and support junior faculty members and create a culture of achievement.... Read more about Lucia Sobrin, MD, MPH, Recognized with Harvard Ophthalmology Excellence in Mentoring Award

Reza Dana, MD, MSc, MPH, and Team of Researchers Develop a Biomaterial for Corneal Repair and Regeneration

March 21, 2019

A clinical research team led by Reza Dana, MD, MSc, MPH, the Claes H. Dohlman Professor of Ophthalmology at Harvard Medical School and Director of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear, have developed a biomaterial for corneal repair and regeneration that could circumvent the need for corneal transplant surgeries. The new technology, named GelCORE (gel for corneal regeneration), is an adhesive gel packed with light-activated chemicals that can seal cuts or ulcers on the cornea and then encourage the regeneration of corneal tissue.

... Read more about Reza Dana, MD, MSc, MPH, and Team of Researchers Develop a Biomaterial for Corneal Repair and Regeneration

Konstantina Sampani Receives 2019 Science Communications Training Fellowship

March 15, 2019

sampani_k

Konstantina Sampani, MD, Clinical Research Fellow at The Beetham Eye Institute at Joslin Diabetes Center, received ARVO's 2019 Science Communications Training Fellowship. The one year program - awarded to just 20 ARVO members - trains young scientists to become more effective communicators of vision research to all audiences.... Read more about Konstantina Sampani Receives 2019 Science Communications Training Fellowship

Saghar Bagheri to Participate in ARVO Members-in-Training Outstanding Poster Award Competition

March 15, 2019

Saghar Bagheri, MD, Clinical Research Fellow at Mass. Eye and Ear under the mentorship of Dr. Demetrios Vavvas, has been invited to participate in the Members-in-Training Outstanding Poster Award Competition at the ARVO Annual Meeting. She received one of the top five scored abstracts in the Retina section for her work entitled, "Anti-VEGF non-responders are often short-term responders." The competition will take place on Tuesday, April 30, 4:15-5:45 p.m., in the Exhibit Hall. Award recipients will be recognized at the Thursday Keynote Session. 
... Read more about Saghar Bagheri to Participate in ARVO Members-in-Training Outstanding Poster Award Competition

Gene Therapy Platform Developed by Neena Haider, PhD, Granted FDA Orphan Drug Designation

February 27, 2019
OCU400, a novel gene therapy platform developed by Neena Haider, PhD, Harvard Medical School Associate Professor of Ophthalmology and Associate Scientist at the Schepens Eye Research Institute of Mass. Eye and Ear, and licensed to biopharmaceutical company Ocugen, Inc., has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA).... Read more about Gene Therapy Platform Developed by Neena Haider, PhD, Granted FDA Orphan Drug Designation